Ginkgo Bioworks Holdings (DNA) Accounts Payables (2020 - 2026)

Ginkgo Bioworks Holdings' Accounts Payables history runs 7 years deep, the most recent figure standing at $16.3 million for Q1 2026.

• Quarterly Accounts Payables rose 44.75% year-over-year to $16.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.3 million (up 44.75% YoY) and the FY2025 annual result came in at $10.6 million, down 25.43% from the prior year.
• Accounts Payables was $16.3 million for Q1 2026 at Ginkgo Bioworks Holdings, up from $10.6 million in the prior quarter.
• Across five years, Accounts Payables topped out at $35.3 million in Q1 2022 and bottomed at $9.3 million in Q4 2023.
• A 5-year average of $16.0 million and a median of $13.6 million in 2023 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2022 — Accounts Payables surged 2379.71% — and 2025, when it tumbled 58.26%.
• Ginkgo Bioworks Holdings' Accounts Payables stood at $10.5 million in 2022, then fell by 10.79% to $9.3 million in 2023, then surged by 51.98% to $14.2 million in 2024, then decreased by 25.43% to $10.6 million in 2025, then jumped by 54.35% to $16.3 million in 2026.
• Business Quant data shows DNA's Accounts Payables at $16.3 million in Q1 2026, $10.6 million in Q4 2025, and $10.7 million in Q3 2025.